If you've been suffering from pelvic pain, including endometriosis-related pain, for more than six months, this study may be for you. The purpose of this study is to test duloxetine as a potential treatment for chronic pelvic pain. Chronic pelvic pain refers to a condition that produces a persistent pain in the lower abdomen, often associated with disorders of pelvic visceral tissue, such as endometriosis. Duloxetine is drug approved by the US Food and Drug Administration (FDA) for the treatment of other types of chronic pain, such as fibromyalgia, osteoarthritis, abd diabetic neuropathy.You can enroll in this treatment study if you are a women 18-50 years old, pre-menopausal, and have been suffering with pelvic pain for six months or more. Participants will be compensated for their time. For additional imformation, contact:CPP Study Coordinator: 443-740-5452Prinicipal Investigator: Dr. Joel D. GreenspanLocation of study: University of Maryland, 650 W. Baltimore St. and 419 Redwood Street.University of Maryland the Founding Campus

By clicking 'Continue', I consent to be contacted regarding education opportunities at the phone number provided: , using an automated telephone dialing system and/or pre-recorded voice. I may be contacted by Career Advisor. Consent is not required as a condition of using this service.